Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Pfizer naming Seán Kelly .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | Pfizer | EU Affairs | PFAS restrictions (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Pfizer | Health | Exchange about the burden of sickle-cell disease in Europe and the Pfizer-supported call to action Shaping the Change for Sickle Cell Disease Patients in Europe and Beyond. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2023 | Pfizer | EU Affairs | EU Pharmaceutical Legislation proposals (Legislation) | 5 | On lobbying.ie |
| Jan–Apr 2023 | Pfizer | EU Affairs | Potential EU proposals to restrict use of titanium dioxide and PFAS in medicines (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Pfizer | EU Affairs | EU Pharmaceutical Legislation (Legislation) | 3 | On lobbying.ie |
| Jan–Apr 2021 | Pfizer | Trade | Highlight importance of IP rights and understand EP actions on possible TRIPS waiver proposal; discuss EU Pharmaceutical Strategy and importance of free trade in medicines and vaccines. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Pfizer | EU Affairs | The EU Commission is introducing legislation for an SPC (Supplementary Protection Certificate) ‘export exemption’; this would allow companies to manufacture products that have an SPC within the EU for export outside the… (Legislation) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| EU Affairs | 5 | 71.4% | |
| Health | 1 | 14.3% | |
| Trade | 1 | 14.3% |